Published in BMC Cancer on January 26, 2006
Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis. Spermatogenesis (2011) 1.16
Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. J Transl Med (2007) 1.05
Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: expression frequency and their correlation with clinical parameters. Int J Clin Exp Pathol (2013) 0.92
Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer. PLoS One (2010) 0.89
Sperm protein 17 is highly expressed in endometrial and cervical cancers. BMC Cancer (2010) 0.85
Potential target antigens for a universal vaccine in epithelial ovarian cancer. Clin Dev Immunol (2010) 0.85
Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines. Cancer Immun (2008) 0.79
Activation of the brain-specific neurogranin gene in murine T-cell lymphomas by proviral insertional mutagenesis. Gene (2009) 0.78
In vivo molecular targeting effects of anti-Sp17- ICG-Der-02 on hepatocellular carcinoma evaluated by an optical imaging system. J Exp Clin Cancer Res (2011) 0.75
Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors. Oncotarget (2015) 0.75
Rethinking immunotherapy for brain cancers in the light of cancer complexity. Indian J Med Res (2013) 0.75
Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer (2005) 9.46
The cancer/testis genes: review, standardization, and commentary. Cancer Immun (2004) 4.78
Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer (2004) 4.73
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev (2002) 4.63
Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst (1999) 3.25
A proteomic analysis of human cilia: identification of novel components. Mol Cell Proteomics (2002) 3.23
Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer (2004) 2.28
Immunotherapy: bewitched, bothered, and bewildered no more. Science (2004) 1.99
The promise of cancer vaccines. Nat Rev Cancer (2004) 1.92
From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens. Trends Immunol (2001) 1.73
Expression of sperm protein 17 (Sp17) in ovarian cancer. Int J Cancer (2004) 1.70
Tumors as elusive targets of T-cell-based active immunotherapy. Trends Immunol (2003) 1.67
Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol (2001) 1.42
Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen. Mol Med (2000) 1.41
Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog (2005) 1.36
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer (2000) 1.34
Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun (2001) 1.31
Expression of cancer testis genes in human brain tumors. Clin Cancer Res (2000) 1.25
Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood (2001) 1.20
Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies. Lancet Oncol (2003) 1.17
Tumor vaccine for ovarian carcinoma targeting sperm protein 17. Cancer (2002) 1.03
Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer (2002) 1.02
The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci (2004) 1.00
Sperm protein 17 is expressed in human somatic ciliated epithelia. J Histochem Cytochem (2004) 0.96
The complexity of anatomical systems. Theor Biol Med Model (2005) 0.96
Immunotherapeutic strategies for malignant glioma. Cancer Control (2004) 0.96
Cancer immunotherapy: avoiding the road to perdition. J Transl Med (2004) 0.95
Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials. Cancer Control (2004) 0.92
Tumor-associated antigens: from discovery to immunity. Int Rev Immunol (2003) 0.91
Cancer genetics/epigenetics and the X chromosome: possible new links for malignant glioma pathogenesis and immune-based therapies. Crit Rev Oncog (2000) 0.90
Immunolocalization of sperm protein 17 in human testis and ejaculated spermatozoa. J Histochem Cytochem (2003) 0.87
Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk. Eur J Immunol (2001) 0.85
Is sperm protein 17 a useful target for tumor immunotherapy? Blood (2003) 0.84
Expression of human sperm protein 17 in melanophages of cutaneous melanocytic lesions. Br J Dermatol (2004) 0.84
Developmental considerations of sperm protein 17 gene expression in rheumatoid arthritis synoviocytes. Dev Immunol (2002) 0.84
MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression. In Vivo (2002) 0.82
Defining tumor antigens: mRNA, protein or cytotoxicity? Trends Immunol (2002) 0.81
MAGE-C1 (CT7) gene expression in multiple myeloma: relationship to sperm protein 17. Eur J Haematol (2002) 0.80
Sperm protein 17 is not expressed on normal leukocytes. Blood (2002) 0.77
Cancer and the nervous system. Med J Aust (2001) 0.76
Some remarks on the somatic expression of sperm protein 17. Int J Cancer (2004) 0.76
Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci (2008) 2.26
Percutaneous vertebral augmentation in metastatic disease: state of the art. J Support Oncol (2011) 2.16
Endoscopic extradural subtemporal approach to lateral and central skull base: a cadaveric study. World Neurosurg (2012) 2.06
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J Exp Med (2011) 2.06
Functional disability after instrumented stabilization in lumbar degenerative spondylolisthesis: a follow-up study. Funct Neurol (2006) 2.00
Expression of sperm protein 17 (Sp17) in ovarian cancer. Int J Cancer (2004) 1.70
Retroperitoneal sarcoma: is it time to change the surgical policy? Ann Surg Oncol (2011) 1.66
An ethanol protocol to prevent alcohol withdrawal syndrome. J Am Coll Surg (2006) 1.55
Endoscopic approaches to the trigeminal nerve and clinical consideration for trigeminal schwannomas: a cadaveric study. J Neurosurg (2012) 1.51
Future directions in training surgical residents to perform endoscopic examinations. Am Surg (2008) 1.42
Local biological factors that influence amputations in diabetic patients. South Med J (2007) 1.39
Reinforcement does not necessarily reduce the rate of staple line leaks after sleeve gastrectomy. A review of the literature and clinical experiences. Obes Surg (2008) 1.36
Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg (2008) 1.25
Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura. J Thorac Oncol (2008) 1.19
A role for the transcription factor HEY1 in glioblastoma. J Cell Mol Med (2008) 1.16
Nanotechnology and human health: risks and benefits. J Appl Toxicol (2010) 1.15
AKAP-4: a novel cancer testis antigen for multiple myeloma. Br J Haematol (2008) 1.11
A comparison of anterior and posterior approaches for the surgical treatment of pancreatic pseudocyst using laparoscopic cystogastrostomy. J Laparoendosc Adv Surg Tech A (2005) 1.08
Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer. Int Rev Immunol (2011) 1.06
Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. J Transl Med (2007) 1.05
Modulation of human T-cell functions by reactive nitrogen species. Eur J Immunol (2011) 1.03
Cancer: looking for simplicity and finding complexity. Cancer Cell Int (2006) 1.01
Hepatoid carcinoma of the pancreas: a case report. Chin Med J (Engl) (2007) 0.98
Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue. J Anat (2007) 0.98
Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood (2002) 0.98
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1. Leukemia (2013) 0.98
Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug. J Neurol Neurosurg Psychiatry (2012) 0.96
Sperm protein 17 is expressed in human somatic ciliated epithelia. J Histochem Cytochem (2004) 0.96
Calvarial metastases as clinical presentation of renal cell carcinoma: report of two cases and review of the literature. Clin Neurol Neurosurg (2005) 0.96
The complexity of anatomical systems. Theor Biol Med Model (2005) 0.96
Reduced collagenolytic activity of matrix metalloproteinases and development of liver fibrosis in the aging rat. Mech Ageing Dev (2002) 0.94
Early cytotoxic effects of ochratoxin A in rat liver: a morphological, biochemical and molecular study. Toxicology (2006) 0.94
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia. J Pathol (2011) 0.93
Multimodal approach to the management of metastatic epidural spinal cord compression (MESCC) due to solid tumors. Int J Radiat Oncol Biol Phys (2010) 0.93
Nonexpanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues. Tissue Eng Part C Methods (2010) 0.93
Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis. Ann Hematol (1999) 0.92
Adipose-derived stem cell therapy for intervertebral disc regeneration: an in vitro reconstructed tissue in alginate capsules. Tissue Eng Part A (2008) 0.92
A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Immunol Rev (2008) 0.92
Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes. Leukemia (2013) 0.92
Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer (2005) 0.92
Laparoscopic splenectomy in blunt trauma. JSLS (2007) 0.92
Fractal analysis of two-dimensional vascularity in primary prostate cancer and surrounding non-tumoral parenchyma. Pathol Res Pract (2009) 0.91
Bladder metastases of appendiceal mucinous adenocarcinoma: a case presentation. BMC Cancer (2010) 0.91
Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage? Expert Opin Biol Ther (2011) 0.90
Surgery for herniated lumbar disc disease: factors influencing outcome measures. An analysis of 403 cases. Funct Neurol (2004) 0.90
Infection, replication, and cytopathology of human papillomavirus type 31 in trophoblasts. Virology (2003) 0.89
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol (2006) 0.89
Unusual cytogenetic findings in a synovial sarcoma arising in the paranasal sinuses. Cancer Genet Cytogenet (2004) 0.89
Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors. In Vitro Cell Dev Biol Anim (2006) 0.89
Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action. Int J Cancer (2005) 0.89
Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today (2008) 0.89
Geometry of human vascular system: is it an obstacle for quantifying antiangiogenic therapies? Appl Immunohistochem Mol Morphol (2007) 0.89
Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Pathol (2008) 0.88
Fractal dimension rectified meter for quantification of liver fibrosis and other irregular microscopic objects. Anal Quant Cytol Histol (2003) 0.88
Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies. Neurosurg Rev (2012) 0.88
Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. J Immunol Methods (2006) 0.87
Immunolocalization of sperm protein 17 in human testis and ejaculated spermatozoa. J Histochem Cytochem (2003) 0.87
Liver fibrosis and tissue architectural change measurement using fractal-rectified metrics and Hurst's exponent. World J Gastroenterol (2006) 0.87
Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer (2010) 0.87
Berengario da Carpi: a pioneer in neurotraumatology. J Neurosurg (2010) 0.86
Association of temporal arteritis, retinal vasculitis, and xanthomatosis with multiple myeloma: case report and literature review. Mayo Clin Proc (1998) 0.86
Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1). Int J Surg Pathol (2008) 0.86
A management algorithm for cerebrospinal fluid leak associated with anterior skull base fractures: detailed clinical and radiological follow-up. Neurosurg Rev (2011) 0.86
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma. PLoS One (2011) 0.86
Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling. BJU Int (2011) 0.86
Biological treatment for liver tumor and new potential biomarkers. Dig Dis Sci (2007) 0.85
Notch-ing from T-cell to B-cell lymphoid malignancies. Cancer Lett (2011) 0.85
Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome. J Clin Oncol (2013) 0.85
Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling. Clin Exp Metastasis (2007) 0.85
The complex functions of mast cells in chronic human liver diseases. Dig Dis Sci (2006) 0.85
Sperm protein 17 is expressed in the sperm fibrous sheath. J Transl Med (2009) 0.84
Is sperm protein 17 a useful target for tumor immunotherapy? Blood (2003) 0.84
Cancer initiation and progression: an unsimplifiable complexity. Theor Biol Med Model (2006) 0.84
The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review. Dig Dis Sci (2007) 0.84